1. Home
  2. STE vs BNTX Comparison

STE vs BNTX Comparison

Compare STE & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STERIS plc (Ireland)

STE

STERIS plc (Ireland)

HOLD

Current Price

$263.47

Market Cap

25.9B

Sector

Health Care

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$96.26

Market Cap

24.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STE
BNTX
Founded
1985
2008
Country
United States
Germany
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.9B
24.8B
IPO Year
1992
2019

Fundamental Metrics

Financial Performance
Metric
STE
BNTX
Price
$263.47
$96.26
Analyst Decision
Buy
Buy
Analyst Count
9
11
Target Price
$268.25
$137.40
AVG Volume (30 Days)
653.3K
1.3M
Earning Date
11-05-2025
11-03-2025
Dividend Yield
0.96%
N/A
EPS Growth
59.39
N/A
EPS
6.97
N/A
Revenue
$5,702,415,000.00
$3,698,814,972.00
Revenue This Year
$9.24
$2.36
Revenue Next Year
$6.30
N/A
P/E Ratio
$37.76
N/A
Revenue Growth
7.08
3.70
52 Week Low
$200.98
$81.20
52 Week High
$268.60
$129.27

Technical Indicators

Market Signals
Indicator
STE
BNTX
Relative Strength Index (RSI) 59.06 39.97
Support Level $256.68 $95.61
Resistance Level $268.60 $98.20
Average True Range (ATR) 4.64 2.93
MACD -0.69 -0.51
Stochastic Oscillator 65.59 22.39

Price Performance

Historical Comparison
STE
BNTX

About STE STERIS plc (Ireland)

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: